IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $812,000 | +16.8% | 41,739 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $695,000 | +98.6% | 41,739 | +51.0% | 0.00% | – |
Q1 2017 | $350,000 | +3.9% | 27,641 | +8.7% | 0.00% | – |
Q4 2016 | $337,000 | -55.3% | 25,429 | -20.1% | 0.00% | -100.0% |
Q3 2016 | $754,000 | +108.3% | 31,818 | +153.2% | 0.00% | 0.0% |
Q2 2016 | $362,000 | -33.1% | 12,564 | -25.6% | 0.00% | 0.0% |
Q1 2016 | $541,000 | -47.7% | 16,881 | -30.3% | 0.00% | -50.0% |
Q4 2015 | $1,035,000 | +38.2% | 24,211 | +13.8% | 0.00% | +100.0% |
Q3 2015 | $749,000 | -67.4% | 21,271 | -57.5% | 0.00% | -80.0% |
Q2 2015 | $2,300,000 | -45.1% | 50,097 | -43.9% | 0.01% | -50.0% |
Q1 2015 | $4,187,000 | +37.0% | 89,326 | -7.4% | 0.01% | +66.7% |
Q4 2014 | $3,056,000 | +4.2% | 96,489 | -22.0% | 0.01% | -25.0% |
Q3 2014 | $2,933,000 | -30.2% | 123,700 | -11.8% | 0.01% | -27.3% |
Q2 2014 | $4,205,000 | +40.6% | 140,200 | +23.9% | 0.01% | +22.2% |
Q1 2014 | $2,991,000 | +16.1% | 113,200 | +10.4% | 0.01% | +12.5% |
Q4 2013 | $2,577,000 | +9.8% | 102,500 | -10.5% | 0.01% | 0.0% |
Q3 2013 | $2,348,000 | +19.0% | 114,500 | +15.8% | 0.01% | +14.3% |
Q2 2013 | $1,973,000 | +183.9% | 98,900 | +191.7% | 0.01% | +133.3% |
Q4 2012 | $695,000 | – | 33,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH TIDE CAPITAL, LLC | 3,000,000 | $37,950,000 | 5.83% |
Healthcare Value Capital, LLC | 200,000 | $2,530,000 | 4.33% |
Ratan Capital Management LP | 354,400 | $4,483,000 | 2.15% |
SECTOR GAMMA AS | 534,311 | $6,759,000 | 1.08% |
Sivik Global Healthcare LLC | 168,030 | $2,126,000 | 0.99% |
Schonfeld Strategic Advisors LLC | 547,157 | $6,922,000 | 0.69% |
Iguana Healthcare Management, LLC | 100,000 | $1,265,000 | 0.63% |
Century Capital Management, LLC | 250,716 | $3,172,000 | 0.50% |
Fosun International Ltd | 300,000 | $3,795,000 | 0.47% |
Atika Capital Management LLC | 39,500 | $499,000 | 0.24% |